natgillin/translations-raw huggingface dataset:
headache, dizziness, tired feeling, shaking chills, fever, flu-like symptoms, virus infection, weakness,
glavobolja, omaglica, osjećaj umora, zimica s tresavicom, vrućica, simptomi nalik gripi, virusna infekcija, slabost,
headache, dizziness, visual field defect dysgeusia,
glavobolja, omaglica, defekt vidnog polja disgeuzija
Headache, dizziness.
glavobolja, omaglica
headache, dizziness†
glavobolja, omaglica
headache, dysgeusia
glavobolja, disgeuzija
Headache, Dysguesia
glavobolja, disgeuzija
Headache, feeling dizzy
glavobolja, osjećaj omaglice
headache, feeling dizzy or feeling weak
glavobolja, omaglica ili osjećaj slabosti
headache, feeling dizzy, restless or sleepy,
glavobolja, omaglica, nemir ili pospanost,
headache, feeling sleepy feeling sick (nausea), dry mouth
glavobolja, osjećaj pospanosti mučnina, suha usta
headache, feeling sleepy feeling sick (nausea), dry mouth
glavobolja, pospanost mučnina, suha usta
headache, feeling sleepy; feeling sick (nausea), dry mouth.
glavobolja, pospanost mučnina, suha usta
Headache, feeling tired.
Glavobolja, osjećaj umora
headache, joint pain urinary tract infection
glavobolja, bol u zglobovima upala mokraćnog sustava.
headache, lethargy (lack of energy), dizziness
glavobolja, letarija (nedostatak energije), omaglica
Headache, Lethargy Dizziness, Parasthesia Dysgeusia
glavobolja, letargija, omaglica, parestezija, disgeuzija
Headache, low blood pressure
glavobolja, nizak krvni tlak
headache, migraine
glavobolja, migrena
headache, muscle pain (myalgia)
glavobolja, bol u mišićima (mialgija)
headache, nausea (feeling sick), fatigue reduction in red blood cells (anaemia)
glavobolja, mučnina, umor smanjenje broja crvenih krvnih stanica (anemija)
Headache, paraesthesia
glavobolja, parestezija
Headache, paraesthesia, dysaesthesia, dizziness
glavobolja, parestezija, dizestezija, omaglica
headache, peripheral neuropathy, dizziness
glavobolja, periferna neuropatija, omaglica
Headache, peripheral sensory neuropathy, paraesthesia, dizziness
glavobolja, periferna senzorna neuropatija, parestezije, omaglica
Headache, pressure in the eyes, nose or cheek area, signs of inflammation of the sinuses and nasal passages (sinusitis)
Glavobolja, tlak u području očiju, nosa ili obraza, znakovi upale sinusa i nosnih puteva (sinusitis)
headache, problems sleeping, depression
glavobolja, problemi sa spavanjem, depresija
headache, shaking (or tremor), dizziness
glavobolja, tresavica (ili tremor), omaglica
headache, sinus headache, dysgeusia
glavobolja, sinusna glavobolja, disgeuzija
Headache, sleep disorders
glavobolja, poremećaji spavanja
Headache, sleepiness, constipation, elevated liver function test, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity
glavobolja, pospanost, zatvor, povišene razine testa jetrene funkcije, omaglica, poremećaji ravnoteže, nedostatak zraka, visoki krvni tlak i preosjetljivost na lijek.
Headache, sleepiness, constipation, elevated liver function test, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity
glavobolja, pospanost, zatvor, povišeni razine testa jetrene funkcije, omaglica, poremećaji ravnoteže, nedostatak zraka, visoki krvni tlak i preosjetljivost na lijek.
Headache, sleepiness, constipation, elevated liver function test, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity.
Glavobolja, pospanost, zatvor, povišeni rezultati testova jetrene funkcije, omaglica, poremećaji ravnoteže, nedostatak zraka, visoki krvni tlak i preosjetljivost na lijek.
headache, sleepiness, dizziness, abnormal sensation in the skin (numbness or tingling sensation), taste changes
glavobolja, pospanost, omaglica, abnormalna osjetljivost kože (obamrlost ili trnci), promjene okusa
headache, sleepiness, dizziness, abnormal sensation in the skin (numbness or tingling sensation), taste changes
glavobolja, pospanost, omaglica, neuobičajeni osjeti na koži (utrnulost ili trnci), promjene osjeta okusa
headache, sleepiness, dizziness, abnormal sensation in the skin (numbness or tingling sensation), taste changes
glavobolja, pospanost, omaglica, poremećaj osjeta na koži (umrtvljenost ili trnci), promjene osjeta okusa
Headache, slurred speech, fast heart beat, cold sweat, cool pale skin, feeling sick (nausea), feeling very hungry, shaking, feeling nervous or worried, unusually tired, weak and sleepy or confused, difficulty concentrating, short-lasting changes in your sight.
Glavobolja, otežani govor, ubrzani otkucaji srca, hladan znoj, hladna blijeda koža, mučnina, osjećaj jake gladi, drhtanje, nervoza ili zabrinutost, osjećaj neuobičajenog umora, slabosti i pospanosti ili smetenosti, poteškoće s koncentracijom, kratkotrajne promjene vida.
headache, stomach pain, feeling tired, feeling bloated, flatulence
glavobolja, bol u trbuhu, umor, nadutost, vjetrovi
headache, tingling or pain in hands or feet, numbness, tiredness, sleeplessness, anxiety;
glavobolja, trnci ili bol u šakama ili stopalima, utrnulost, umor, nesanica, tjeskoba;
headache, tiredness;
glavobolja, umor,
headache, weakness
glavobolja, slabost
headache.
glavobolja;
Headache1
glavobolja1
headache1, 2, 3, dizziness1, 2, 3
glavobolja1, 2, 3, omaglica1, 2, 3
Headache3
Glavobolja3,
Headache3 Dizziness3 Tremor2
Glavobolja3 Omaglica3 Tremor2
Headache3)
Glavobolja3)
Headache3,
Glavobolja3
Headache6
glavobolja6
headache;
glavobolja,
headache;
glavobolja;
Headache; Dizziness
glavobolja; omaglica
headache; dizziness, tiredness; swelling in the hands or legs.
glavobolja, omaglica, umor, oticanje šaka ili nogu.
headache; dizziness; change in your sense of taste
glavobolja; omaglica; promjena osjeta okusa
Headache; fainting; nerve disorders which can cause weakness, tingling, or numbness; eye nerve disturbances.
glavobolja; nesvjestica; živčani poremećaj koji može uzrokovati slabost, osjećaj trnjenja ili obamrlost; smetnje očnog živca
headache; feeling dizzy
glavobolja; omaglica
Headache; injection site reaction; peripheral oedema.
Glavobolja, reakcije na mjestu injiciranja, periferni edem.
Headache; Somnolence
glavobolja; somnolencija
Headachea
glavoboljaa
Headached
glavoboljad
Headacheh, paraesthesiah
Glavoboljah, parestezijah
Headaches
Glavobolja
Headaches
Glavobolje
headaches (including migraine), sensory abnormalities
glavobolje (uključujući migrenu), poremećaji osjeta
headaches (including migraines)
glavobolje (uključujući migrenu)
Headaches, believed to be caused by filgrastim, have been reported in PBPC donor studies.
U ispitivanjima s davateljima progenitorskih stanica periferne krvi prijavljivani su slučajevi glavobolje za koju se mislilo da je prouzročena filgrastimom.
Headaches, confusion, seizures (fits), visual loss, and high blood pressure (hypertension), which may be symptoms of a neurologic condition known as posterior reversible encephalopathy syndrome (PRES).
Glavobolje, smetenost, napadaji, gubitak vida i visok krvni tlak (hipertenzija) koji mogu biti simptomi neurološkog stanja poznatog kao sindrom posteriorne reverzibilne encefalopatije (PRES).
headaches, dizziness, or feeling weak
glavobolje, omaglicu ili osjećaj slabosti
headaches, dizziness, or weakness
glavobolju, omaglicu ili slabost
Headaches, feeling of “spinning” (vertigo), loss of balance, trembling
glavobolje, osjećaj vrtnje (vrtoglavica), gubitak ravnoteže, drhtanje
Headaches, high blood pressure and visual disturbances, which are symptoms of a condition called reversible posterior leukoencephalopathy syndrome;
glavobolje, visoki krvni tlak i smetnje vida, koji su simptomi stanja koje se naziva sindrom reverzibilne posteriorne leukoencefalopatije;
headaches, migraines or tension headaches
glavobolje, migrene ili tenzijske glavobolje
Headaches, particularly sudden, stabbing migraine-like headaches, feeling confused or having fits may be signs of a sudden increase in blood pressure.
Glavobolje, osobito iznenadne, probadajuće, migreni nalik glavobolje, osjećaj smetenosti ili napadaji mogu biti znakovi naglog povišenja krvnog tlaka.
Headaches.
Glavobolje.
Headache†
Glavobolja
healing is achieved.
dana, do zacjeljivanja.
Health Care Ltd.
EU/1/14/911/003
Health Care Professional (HCP) Checklist for Phototoxicity, SCC and Hepatic toxicity:
Kontrolni popis za zdravstvenog radnika za fototoksičnost, SCC i toksičnost za jetru:
Health Care Professional (HCP) Checklist for Phototoxicity, SCC and Hepatic toxicity:
Kontrolni spisak za zdravstvenog radnika za fototoksičnost, SCC te za toksičnosti za jetru:
Health Care Professional (HCP) Question and Answer Brochure for Phototoxicity, SCC and Hepatic toxicity;
Brošura za zdravstvenog radnika s pitanjima i odgovorima o fototoksičnosti, SCC-u te o toksičnosti za jetru;
Health care professional brochure including a detailed calculation of number of vials for a patient weighing for example 70 kg
Brošuru za zdravstvene radnike koja uključuje detaljni izračun broja bočica za bolesnika koji, primjerice, teži 70 kg
Health Care Professional information
Informacija za zdravstvene djelatnike
Health care professional information
Informacije za zdravstvene radnike
Health care professionals should wear nitrile gloves when handling patches and cleansing treatment areas.
Zdravstveni djelatnici trebaju nositi nitrilne rukavice za vrijeme rukovanja flasterima i čišćenja područja liječenja.
Health care professionals should wear nitrile gloves when handling patches and when cleansing treatment areas (see section 4.2).
Zdravstveni djelatnici moraju nositi nitrilne rukavice za vrijeme rukovanja flasterima i čišćenja područja liječenja (vidjeti dio 4.2).
Health care providers need to assess the benefits and potential risks of administering Foclivia vaccine to pregnant women, taking into consideration official recommendations.
Liječnici trebaju procijeniti koristi i moguće rizike primjene cjepiva Foclivia kod trudnica, uzimajući u obzir službene preporuke.
Health experts recommend that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.
Ženama s HIV infekcijom liječnici preporučuju da ne doje svoju djecu ni u kojim okolnostima, kako bi izbjegle prijenos HIV-a.
Health-related and quality of life outcomes
Zdravstveni ishodi i ishodi povezani s kvalitetom života
Health-related and quality of life outcomes in studies G2305 and G2301
Ishodi povezani sa zdravljem i kvalitetom života u ispitivanjima G2305 i G2301
Health-related quality of life was assessed by the SF-36 questionnaire at 6 months in Studies I, II, and III and at 12 months in Studies I and II.
Kvaliteta života vezana uz zdravlje ocijenjena je pomoću upitnika SF-36 nakon 6 mjeseci u Ispitivanjima I, II i III te nakon 12 mjeseci u Ispitivanjima I i II.
Healthcaare professionals are asked to report any suspected adverse reactions.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu za ovaj lijek.
Healthcare personnel are advised to limit the time of close contact with patients injected with 64Cu-radiopharmaceuticals.
Medicinskom osoblju se savjetuje da se ograniči vrijeme bliskog kontakta s pacijentima kojima su ubrizgani 64Cu-radiofarmaceutici.
Healthcare professional A4 laminated titration guide;
Vodič za titraciju doze za zdravstvenog radnika na plastificiranom kartonu A4 formata;
Healthcare professional booklet
knjižicu za zdravstvene djelatnike
Healthcare Professional brochure containing information about Opsumit;
Brošuru za zdravstvene djelatnike koja sadrži informacije o lijeku Opsumit;
Healthcare professional checklist
Kontrolni popis za zdravstvenog djelatnika
Healthcare professional educational material
Edukacijske materijale za zdravstvene djelatnike
HEALTHCARE PROFESSIONAL EDUCATIONAL STICKER
EDUKACIJSKA NALJEPNICA ZA ZDRAVSTVENE DJELATNIKE
Healthcare professional Frequently Asked Questions (FAQ) Brochure
Knjižicu s čestim pitanjima za zdravstvene radnike
Healthcare Professional information pack
Paket s informacijama za zdravstvenog djelatnika
Healthcare professional information regarding Volibris
Materijale za informiranje zdravstvenih radnika o lijeku Volibris
Healthcare professional reminder card
Karticu-podsjetnik za zdravstvene djelatnike
Healthcare professionals are advised not to dispose of unused Zoledronic acid Actavis via the domestic sewage system.
Zdravstvenim djelatnicima se savjetuje da ne uklanjaju neiskorištenu Zoledronatnu kiselinu Actavis putem kanalizacije.
Healthcare professionals are advised not to dispose of unused Zoledronic Acid Hospira via the domestic sewage system.
Zdravstvenim djelatnicima se savjetuje da ne bacaju neiskorištenu Zoledronatnu kiselinu Hospira u otpadne vode.
Healthcare professionals are advised not to dispose of unused Zoledronic acid Mylan via the domestic sewage system.
Zdravstvenim djelatnicima se savjetuje da ne uklanjaju neiskorištenu Zoledronatnu kiselinu Mylan putem kanalizacijskog sustava.
Healthcare professionals are advised not to dispose of unused Zoledronic acid Teva via the domestic sewage system.
Zdravstvenim djelatnicima se savjetuje da ne uklanjaju neiskorištenu Zoledronatnu kiselinu Teva putem kanalizacije.
Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system in Appendix V.
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V*.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V
Od zdrastvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V*.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu za ovaj lijek putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V*
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V*.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka na adresu
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V*.
Od zdravstvenih djelatnika traži se da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od liječnika se očekuje da prijave sve moguće nuspojave putem nacionalnog sustava prijavljivanja navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdrastvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V*.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdrastvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave bilo koju sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku nuspojvau lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojave lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijava nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava Agencija za lijekove i medicinske proizvode (HALMED)
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava na:
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatak V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V .
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u nacionalnog sustava za prijavu nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog uDodatku V .
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog uDodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojave navedenog u Dodatku V
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojave navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijavljivanja navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prije nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijeve nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem putem nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu putem nacionalnog sustava za prijavljivanje nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih djelatnika traži se da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava za prijavu nuspojava navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih radnika se traţi da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava: navedenog u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava koji je naveden u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenih u Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u 0Dodatku V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog u Appendix V.